AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract HHSN272201400053CVAXINE PTY LTD
Overview
Award facts
- Net obligations
- $11.28M
- $11,281,569of $11.28M potential value
- Outlays (paid to date)
- $500K
- $500K paid of $11.28M obligated$500,000
- Period of performance
- Sep 23, 2014 to Sep 29, 2021
- Ended
- Modifications
- 14
- Latest action Nov 24, 2021
- Contract type
- Definitive contract
- PIID HHSN272201400053C
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
IGF::OT::IGF ADJUVANT DISCOVERY PROGRAM
Dates and value
- Award date
- Signed on Sep 23, 2014
- Potential end of performance
- Sep 28, 2021
- Current value
- $11,281,569Base and exercised options
- Potential value (if all options are exercised)
- $11,281,569
Obligations by fiscal year of action
- FY2022: -$4,922 (de-obligation)
- FY2020: $500,000
- FY2019: $413,000
- FY2018: $1,904,860
- FY2017: $320,000
- FY2016: $400,000
- FY2014: $7,748,631
Total across 7 fiscal years: $11,281,569
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Nov 24, 2021. View on USAspending · Recipient on SAM.gov
Recipient
NameVAXINE PTY LTD
LocationBEDFORD PARK, AUS
UEIZ9AUC2SNX5A4
CAGE codeZ0ED5
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeInternational org
Parent companyVAXINE PTY LTD
Business types and certifications
Foreign-ownedFor-profit organizationInternational organization
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Australia
Classification and competition
Classification
- Product or service (PSC)
- AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost no feeS
- Offers received
- 16
Contract details
- Subcontracting plan
- Plan required - incentive not includedC
- Major program
- Adjuvant discovery program
- Cost Accounting Standards clause
- Yes - CAS clause includedY
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 23, 2014Base obligation at award: $7,748,631
- Latest action
- Nov 24, 2021 — CloseoutModification P00014; obligation change -$4,922; administrative: no change in scope or value
- Latest substantive action
- Apr 7, 2020 — Change orderModification P00013; obligation change +$500,000
- Actions by type
- Base award1
- Change order6
- Other administrative action6
- Option exercised1
- Closeout1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$4,922
- Latest action: change in base and all options
- -$4,922
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Contingency, humanitarian or peacekeeping operation
- Presidential issued emergency declaration, or a major disaster declarationC
Place and origin
- Domestic or foreign entity
- Foreign-owned business not incorporated in the U.S.D
- Country of product or service origin
- AustraliaAUS
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 15
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2017/2017-0885-000
- 075-2018/2018-0885-000
- 075-2019/2019-0885-000
- 075-2020/2024-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- L: Emergency P.L. 116-123
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- COVID-19 supplemental obligations
- $500,000
- COVID-19 supplemental outlays
- $500,000